Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. Moreira RS, da Silva MM, de Melo Vasconcelos CF, da Silva TD, et al. J Cancer Res Clin Oncol 2023 Oct 16. doi: 10.1007/s00432-023-05437.

Read + Share

Amedeo Smart

Independent Medical Education

Moreira RS, da Silva MM, de Melo Vasconcelos CF, da Silva TD, et al. Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. J Cancer Res Clin Oncol 2023 Oct 16. doi: 10.1007/s00432-023-05437.
PMID: 37843557